Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
McKinsey & Company has agreed to pay $650 million to resolve investigations related to its involvement in the promotion of OxyContin, a painkiller produced by Purdue Pharma. This settlement follows a lawsuit that scrutinized the consulting firm's role in the opioid crisis, which has drawn significant public and governmental concern. The resolution includes a Corporate Integrity Agreement, marking a notable step in addressing the firm's past actions linked to the opioid epidemic. The settlement was announced amidst broader discussions about healthcare fraud and the regulatory landscape surrounding Medicare Advantage organizations.
First-Ever Corporate Integrity Agreement with Consulting Firm in Opioid Crisis-Related Resolution of Civil and Criminal Investigations https://t.co/ru48gNy4GB #Health #Crime #Laws @CarlaKJohnson @sarahkliff https://t.co/hst8Ywi7o0
The OIG’s Concerns with Potentially Fraudulent Medicare Advantage Marketing https://t.co/j7SotLaUZ7 #Health #Crime #Government @Polsinelli https://t.co/cr5iiSrciE
This week's Legal Lions leader comes from the public sector, as federal prosecutors secured a $650 million settlement from McKinsey & Co. to resolve a lawsuit over the consulting giant's role in Purdue Pharma's promotion of OxyContin. https://t.co/qfwL6NRZRu
